Vera Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.2M | $83.7M | $79.7M |
| FY2022 | $54.5M | $131.4M | $43.5M |
| FY2023 | $73.9M | $175.5M | $45.7M |
| FY2024 | $78.5M | $655.7M | $92.6M |
| FY2025 | $130.2M | $734.7M | $354.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.2M | $83.7M | $79.7M |
| FY2022 | $54.5M | $131.4M | $43.5M |
| FY2023 | $73.9M | $175.5M | $45.7M |
| FY2024 | $78.5M | $655.7M | $92.6M |
| FY2025 | $130.2M | $734.7M | $354.7M |